The opioid ligand binding of human μ-opioid receptor is modulated by novel splice variants of the receptor

Biochemical and Biophysical Research Communications

Volumn 343, Issue 4, 2006, Pages 1132-1140

  Choi, Hack Sun ^a   Kim, Chun Sung ^a   Hwang, Cheol Kyu ^a   Song, Kyu Young ^a   Wang, Wei ^a   Qiu, Yu ^a   Law, Ping Yee ^a   Wei, Li Na ^a   Loh, Horace H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Opioid receptor; Bioluminescence resonance energy transfer; BRET; Destabilized red fluorescence protein; DsRed; MOR; Renilla luciferase; Rluc; Splice variant; SV; TM; Transmembrane domain

Indexed keywords

DIPRENORPHINE; HETERODIMER; MU OPIATE RECEPTOR; OPIATE; PROTEIN SUBUNIT;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BRAIN; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTRON; MOLECULAR WEIGHT; NEUROBLASTOMA CELL; PREDICTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN VARIANT; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; BRAIN; CELL LINE, TUMOR; DIMERIZATION; DIPRENORPHINE; EXONS; HUMANS; INTRONS; LIGANDS; MOLECULAR SEQUENCE DATA; NARCOTIC ANTAGONISTS; NEUROBLASTOMA; PROTEIN STRUCTURE, TERTIARY; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, MU; TRITIUM;

RENILLA LUCIFERASE;

EID: 33646017709     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.084     Document Type: Article

References (49)

1. Min B.H., Augustin L.B., Felsheim R.F., Fuchs J.A., and Loh H.H. Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc. Natl. Acad. Sci. USA 91 (1994) 9081-9085
2. Kieffer B.L. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol. Neurobiol. 15 (1995) 615-635
3. Kieffer B.L. Opioids: first lessons from knockout mice. Trends Pharmacol. Sci. 20 (1999) 19-26
4. Law P.Y., Wong Y.H., and Loh H.H. Molecular mechanisms and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 389-430
5. Mansour A., Fox C.A., Akil H., and Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18 (1995) 22-29
6. Sedqi M., Roy S., Ramakrishnan S., Elde R., and Loh H.H. Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 209 (1995) 563-574
7. Donahoe R.M., and Vlahov D. Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J. Neuroimmunol. 83 (1998) 77-87
8. Nyland S.B., Specter S., Im-Sin J., and Ugen K.E. Opiate effects on in vitro human retroviral infection. Adv. Exp. Med. Biol. 437 (1998) 91-100
9. Sheng W.S., Hu S., Gekker G., Zhu S., Peterson P.K., and Chao C.C. Immunomodulatory role of opioids in the central nervous system. Arch. Immunol. Ther. Exp. (Warsz) 45 (1997) 359-366
10. Wang J.B., Imai Y., Eppler C.M., Gregor P., Spivak C.E., and Uhl G.R. mu opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA 90 (1993) 10230-10234
11. Chen Y., Mestek A., Liu J., Hurley J.A., and Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol. Pharmacol. 44 (1993) 8-12
12. Fukuda K., Kato S., Mori K., Nishi M., and Takeshima H. Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes. FEBS Lett. 327 (1993) 311-314
13. Bare L.A., Mansson E., and Yang D. Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett. 354 (1994) 213-216
14. Pan Y.X., Xu J., Mahurter L., Xu M., Gilbert A.K., and Pasternak G.W. Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1X. Biochem. Biophys. Res. Commun. 301 (2003) 1057-1061
15. Zimprich A., Simon T., and Hollt V. Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett. 359 (1995) 142-146
16. Pan Y.X., Xu J., Bolan E., Abbadie C., Chang A., Zuckerman A., Rossi G., and Pasternak G.W. Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms. Mol. Pharmacol. 56 (1999) 396-403
17. Pan Y.X., Xu J., Bolan E., Chang A., Mahurter L., Rossi G., and Pasternak G.W. Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F. FEBS Lett. 466 (2000) 337-340
18. Pan Y.X., Xu J., Mahurter L., Bolan E., Xu M., and Pasternak G.W. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc. Natl. Acad. Sci. USA 98 (2001) 14084-14089
19. Kwon J.H., Keates S., Simeonidis S., Grall F., Libermann T.A., and Keates A.C. ESE-1, an enterocyte-specific Ets transcription factor, regulates MIP-3alpha gene expression in Caco-2 human colonic epithelial cells. J. Biol. Chem. 278 (2003) 875-884
20. Kvam T.M., Baar C., Rakvag T.T., Kaasa S., Krokan H.E., and Skorpen F. Genetic analysis of the murine micro opioid receptor: increased complexity of Oprm gene splicing. J. Mol. Med. 82 (2004) 250-255
21. Rossi G.C., Pan Y.X., Brown G.P., and Pasternak G.W. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor. FEBS Lett. 369 (1995) 192-196
22. Rossi G.C., Leventhal L., Pan Y.X., Cole J., Su W., Bodnar R.J., and Pasternak G.W. Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception. J. Pharmacol. Exp. Ther. 281 (1997) 109-114
23. Pan L., Xu J., Yu R., Xu M.M., Pan Y.X., and Pasternak G.W. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm. Neuroscience 133 (2005) 209-220
24. Mizoguchi H., Wu H.E., Narita M., Loh H.H., Nagase H., and Tseng L.F. Loss of mu-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of mu-opioid receptor gene. Neurosci. Lett. 335 (2002) 91-94
25. Pin J.P., Kniazeff J., Binet V., Liu J., Maurel D., Galvez T., Duthey B., Havlickova M., Blahos J., Prezeau L., and Rondard P. Activation mechanism of the heterodimeric GABA(B) receptor. Biochem. Pharmacol. 68 (2004) 1565-1572
26. Kniazeff J., Bessis A.S., Maurel D., Ansanay H., Prezeau L., and Pin J.P. Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat. Struct. Mol. Biol. 11 (2004) 706-713
27. Nelson G., Chandrashekar J., Hoon M.A., Feng L., Zhao G., Ryba N.J., and Zuker C.S. An amino-acid taste receptor. Nature 416 (2002) 199-202
28. Filipek S., Krzysko K.A., Fotiadis D., Liang Y., Saperstein D.A., Engel A., and Palczewski K. A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface. Photochem. Photobiol. Sci. 3 (2004) 628-638
29. Fotiadis D., Liang Y., Filipek S., Saperstein D.A., Engel A., and Palczewski K. The G protein-coupled receptor rhodopsin in the native membrane. FEBS Lett. 564 (2004) 281-288
30. Jordan B.A., and Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399 (1999) 697-700
31. George S.R., Fan T., Xie Z., Tse R., Tam V., Varghese G., and O'Dowd B.F. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J. Biol. Chem. 275 (2000) 26128-26135
32. Gomes I., Gupta A., Filipovska J., Szeto H.H., Pintar J.E., and Devi L.A. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc. Natl. Acad. Sci. USA 101 (2004) 5135-5139
33. He L., Fong J., von Zastrow M., and Whistler J.L. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108 (2002) 271-282
34. Hwang C.K., Kim C.S., Choi H.S., McKercher S.R., and Loh H.H. Transcriptional regulation of mouse mu opioid receptor gene by PU.1. J. Biol. Chem. 279 (2004) 19764-19774
35. Choi H.S., Hwang C.K., Kim C.S., Song K.Y., Law P.Y., Wei L.N., and Loh H.H. Transcriptional regulation of mouse mu opioid receptor gene: Sp3 isoforms (M1, M2) function as repressors in neuronal cells to regulate the mu opioid receptor gene. Mol. Pharmacol. 67 (2005) 1674-1683
36. Wang D., Sun X., Bohn L.M., and Sadee W. Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer. Mol. Pharmacol. 67 (2005) 2173-2184
37. Lewis B.P., Green R.E., and Brenner S.E. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. USA 100 (2003) 189-192
38. Wagner E., and Lykke-Andersen J. mRNA surveillance: the perfect persist. J. Cell Sci. 115 (2002) 3033-3038
39. Maquat L.E. Nonsense-mediated mRNA decay. Curr. Biol. 12 (2002) R196-R197
40. Gaveriaux-Ruff C K.B. Opioid receptor: gene structure and function. In: Stein C. (Ed). Opioids in Pain Control (1999), Cambridge University Press, Cambridge
41. Koch T., Schulz S., Schroder H., Wolf R., Raulf E., and Hollt V. Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273 (1998) 13652-13657
42. Koch T., Schulz S., Pfeiffer M., Klutzny M., Schroder H., Kahl E., and Hollt V. C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. J. Biol. Chem. 276 (2001) 31408-31414
43. Abbadie C., Pan Y.X., and Pasternak G.W. Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C-like and MOR-1-like immunoreactivity: evidence for region-specific processing. J. Comp. Neurol. 419 (2000) 244-256
44. Abbadie C., Pan Y., Drake C.T., and Pasternak G.W. Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS. Neuroscience 100 (2000) 141-153
45. Abbadie C., Gultekin S.H., and Pasternak G.W. Immunohistochemical localization of the carboxy terminus of the novel mu opioid receptor splice variant MOR-1C within the human spinal cord. Neuroreport 11 (2000) 1953-1957
46. Xin L., and Wang Z.J. Bioinformatic analysis of the human mu opioid receptor (OPRM1) splice and polymorphic variants. AAPS PharmSci. 4 (2002) E23
47. Dean M.K., Higgs C., Smith R.E., Bywater R.P., Snell C.R., Scott P.D., Upton G.J., Howe T.J., and Reynolds C.A. Dimerization of G-protein-coupled receptors. J. Med. Chem. 44 (2001) 4595-4614
48. Filizola M., and Weinstein H. Structural models for dimerization of G-protein coupled receptors: the opioid receptor homodimers. Biopolymers 66 (2002) 317-325
49. Fan T., Varghese G., Nguyen T., Tse R., O'Dowd B.F., and George S.R. A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. J. Biol. Chem. 280 (2005) 38478-38488